STOCK TITAN

BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Bio-Techne Corporation (NASDAQ: TECH) will have its President, Will Geist, present at the KeyBanc Life Sciences & MedTech Investor Forum on March 19, 2024. The presentation will be available via a live webcast on the company's Investor Relations website.
Positive
  • None.
Negative
  • None.

MINNEAPOLIS, March 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Will Geist, President, Protein Sciences Segment, will present at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:45 a.m. EDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne (NASDAQ: TECH)

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit http://www.bio-techne.com or follow the Company on social media at Facebook, LinkedIn, Twitter or YouTube.

Contact:

David Clair, Vice President, Investor Relations & Corporate Development



david.clair@bio-techne.com



612-656-4416


Bio-Techne

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-keybanc-life-sciences--medtech-investor-forum-302086247.html

SOURCE Bio-Techne Corporation

FAQ

When will Will Geist present at the KeyBanc Life Sciences & MedTech Investor Forum?

Will Geist will present on March 19, 2024, at 9:45 a.m. EDT.

Where can the live webcast of the presentation be accessed?

The live webcast can be accessed on Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

Bio-Techne Corporation

NASDAQ:TECH

TECH Rankings

TECH Latest News

TECH Stock Data

13.03B
155.39M
0.97%
100.54%
3.39%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
MINNEAPOLIS

About TECH

bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.